Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling.
about
Targeted therapy for HM1.24 (CD317) on multiple myeloma cellsChanges in the transcriptome of the human endometrial Ishikawa cancer cell line induced by estrogen, progesterone, tamoxifen, and mifepristone (RU486) as detected by RNA-sequencingOverexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer.ZIC1 modulates cell-cycle distributions and cell migration through regulation of sonic hedgehog, PI(3)K and MAPK signaling pathways in gastric cancer.Dkk4 and Eda regulate distinctive developmental mechanisms for subtypes of mouse hair.Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.Gene expression profiling supports the hypothesis that human ovarian surface epithelia are multipotent and capable of serving as ovarian cancer initiating cells.ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancerThe novel immunotoxin HM1.24-ETA' induces apoptosis in multiple myeloma cells.Laser capture microdissection with genome-wide expression profiling displayed gene expression signatures in endometrioid endometrial cancer.Molecular mechanism of arenavirus assembly and budding.Gene expression analysis of early stage endometrial cancers reveals unique transcripts associated with grade and histology but not depth of invasion.Epigenetic inactivation of EFEMP1 is associated with tumor suppressive function in endometrial carcinoma.Altered protein expression in serum from endometrial hyperplasia and carcinoma patients.Bone marrow stromal antigen 2 expressed in cancer cells promotes mammary tumor growth and metastasis.Estrogen mediated expression of nucleophosmin 1 in human endometrial carcinoma clinical stages through estrogen receptor-α signaling.The expression of BST2 in human and experimental mouse brain tumors.Minireview: The roles of small RNA pathways in reproductive medicinemiREC: a database of miRNAs involved in the development of endometrial cancer.Bone marrow stromal antigen 2 (BST-2) DNA is demethylated in breast tumors and breast cancer cells.ZIC1 overexpression is oncogenic in liposarcoma.Zic1 Promoter Hypermethylation in Plasma DNA Is a Potential Biomarker for Gastric Cancer and Intraepithelial Neoplasia.The multifaceted roles of neutrophil gelatinase associated lipocalin (NGAL) in inflammation and cancerEnolase-1 is a therapeutic target in endometrial carcinoma.Neutrophil chemokines secreted by tumor cells mount a lung antimetastatic response during renal cell carcinoma progression.Gene expression profiling of the synergy of 5-aza-2'-deoxycytidine and paclitaxel against renal cell carcinoma.CXCL5 promotes prostate cancer progressionIdentification and validation of a gene expression signature that predicts outcome in adult men with germ cell tumorsSearching for molecular markers in head and neck squamous cell carcinomas (HNSCC) by statistical and bioinformatic analysis of larynx-derived SAGE libraries.EFEMP1 is repressed by estrogen and inhibits the epithelial-mesenchymal transition via Wnt/β-catenin signaling in endometrial carcinoma.Elevated MiR-222-3p promotes proliferation and invasion of endometrial carcinoma via targeting ERα.Overexpression of microRNA-205 predicts lymph node metastasis and indicates an unfavorable prognosis in endometrial cancer.The MYC, TERT, and ZIC1 genes are common targets of viral integration and transcriptional deregulation in avian leukosis virus subgroup J-induced myeloid leukosis.Over-expression of platelet-derived growth factor-D promotes tumor growth and invasion in endometrial cancer.Olfactomedin 1 negatively regulates NF-κB signalling and suppresses the growth and metastasis of colorectal cancer cells.Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.Dysregulation of microRNA-204 mediates migration and invasion of endometrial cancer by regulating FOXC1.CKMT1 and NCOA1 expression as a predictor of clinical outcome in patients with advanced-stage head and neck squamous cell carcinoma.Preoperative imaging markers and PDZ-binding kinase tissue expression predict low-risk disease in endometrial hyperplasias and low grade cancersMolecular diagnosis of endometrial cancer from uterine aspirates.
P2860
Q27026161-68543E35-7789-4064-A06B-CEC33210CFCAQ28677420-B3850A3D-442C-49B0-AC67-26B626766C7DQ30427989-FA35D095-A650-4334-9A67-3D82F785E7D7Q31073715-98635BA8-0E1A-4719-AA6A-10907742ECE4Q33348928-CA621F64-C6B6-4A55-98FA-E0EB2874849BQ33425484-C99395B2-0851-4FE7-BA51-32D9787B88C2Q33521103-39DED1B9-7435-435D-AA4B-BBCAB1505DBAQ33828288-F293A453-CCEA-4FBE-BC22-226F6FD5B6BCQ33840201-7CDEE52E-6A95-4F46-8CB1-2CDA36DABB75Q34084754-5F9AE7AF-67BC-48F5-A7EA-342296F9FD7BQ34645914-93A13427-8083-41B5-9144-7AAF62859FD5Q34779117-188BDB54-D0EE-46B2-9BA5-EC8CF8122A78Q34807396-F54E6A3E-964D-4484-B01B-A932D4D21254Q34989853-BACADBFF-D245-4452-AA38-DE4157A5B41DQ35021021-06A29226-5C69-4966-AC6E-ACDAD6D790E3Q35056262-88BA9DDA-C9F2-4778-8D65-3454869D9089Q35115811-008B571C-5388-4D3F-92F2-A75C7CE9EC7BQ35135678-88CAECF5-A9B3-45EB-8186-EEE61606FA38Q35247692-A183EEDE-A898-4701-A445-F614848E9E9CQ35362935-E2961FFE-BF52-4117-90BD-0B25470701B9Q35699924-A6A42D79-20C9-4375-8375-40F8FADA7411Q35711210-D0FFE8C8-BB80-4CBF-96F8-C2D41DD55B77Q35996059-73E6D6C0-0F57-449C-941A-220F483DAC42Q36021076-24F7899F-142F-421E-9596-B87FD617E67DQ36213700-B20BC72F-2D7D-436C-8C8E-0B7BBEDF06F7Q36348109-49C6668C-AE36-4167-9C1C-36A65B203CCCQ36487549-F65E092E-0433-4636-BA51-C6AC49362DFBQ36836098-B900E765-40B8-4CE3-88FA-8901B47BC6AAQ37069802-EFD58FBE-EE13-45F7-8132-95DA06894626Q37295470-D41C4AC5-E8A0-4244-B97E-6F451E873092Q37539078-ACE91564-34E3-4A97-BB55-3332BCE16599Q37582086-9E4EC55D-DE4B-4A89-A346-390BD007E0CDQ37643805-78884470-B5BE-4EAB-AB9E-A3C46FB7C92BQ37684112-E8B08274-98F9-4B34-BA99-5CDC02D2DD3AQ38740059-B68D4855-D04E-420A-9AE5-DD9B84DF5A1CQ39325995-92BAEF73-D917-442A-8CA3-868F4BECCEF2Q39576706-0AA25280-15F5-48AF-AE92-BD217B360006Q40375971-0693B5EB-D10F-42D0-B9CB-E66B0217665CQ41878396-66348383-EC63-4B65-9CDC-9637702112E3Q44593249-E83975C5-E324-4BEB-9DF0-AA33CA5DDADB
P2860
Identification of molecular markers and signaling pathway in endometrial cancer in Hong Kong Chinese women by genome-wide gene expression profiling.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Identification of molecular ma ...... ide gene expression profiling.
@en
Identification of molecular ma ...... ide gene expression profiling.
@nl
type
label
Identification of molecular ma ...... ide gene expression profiling.
@en
Identification of molecular ma ...... ide gene expression profiling.
@nl
prefLabel
Identification of molecular ma ...... ide gene expression profiling.
@en
Identification of molecular ma ...... ide gene expression profiling.
@nl
P2093
P2860
P356
P1433
P1476
Identification of molecular ma ...... wide gene expression profiling
@en
P2093
Gardner GJ
Johnson WB
P2860
P2888
P304
P356
10.1038/SJ.ONC.1209986
P407
P577
2006-10-16T00:00:00Z